202 related articles for article (PubMed ID: 18661518)
1. Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer.
Skírnisdóttir I; Garmo H; Wilander E; Holmberg L
Int J Cancer; 2008 Oct; 123(8):1897-901. PubMed ID: 18661518
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival in women with borderline ovarian tumors: a population-based survey of borderline ovarian tumors in Sweden 1960-2007.
Kalapotharakos G; Högberg T; Bergfeldt K; Borgfeldt C
Acta Obstet Gynecol Scand; 2016 Apr; 95(4):473-9. PubMed ID: 26714557
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
Jordan SJ; Green AC; Whiteman DC; Webb PM;
Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
[TBL] [Abstract][Full Text] [Related]
4. Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: occurrence, origin and survival compared to ovarian cancer.
Skírnisdóttir I; Garmo H; Holmberg L
Gynecol Oncol; 2007 Apr; 105(1):166-71. PubMed ID: 17184826
[TBL] [Abstract][Full Text] [Related]
5. Histology-specific long-term trends in the incidence of ovarian cancer and borderline tumor in Japanese females: a population-based study from 1983 to 2007 in Niigata.
Yahata T; Banzai C; Tanaka K;
J Obstet Gynaecol Res; 2012 Apr; 38(4):645-50. PubMed ID: 22381138
[TBL] [Abstract][Full Text] [Related]
6. Trends in incidence of borderline ovarian tumors in Denmark 1978-2006.
Hannibal CG; Huusom LD; Kjaerbye-Thygesen A; Tabor A; Kjaer SK
Acta Obstet Gynecol Scand; 2011 Apr; 90(4):305-12. PubMed ID: 21306323
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of second cancer among patients with ovarian borderline tumors.
Bouchardy C; Fernandez S; Merglen A; Usel M; Fioretta G; Rapiti E; Schubert H; Pelte MF; Chappuis PO; Vlastos G
Gynecol Oncol; 2008 May; 109(2):210-4. PubMed ID: 18377966
[TBL] [Abstract][Full Text] [Related]
9. Declining trends of epithelial ovarian cancer in California.
Morris CR; Rodriguez AO; Epstein J; Cress RD
Gynecol Oncol; 2008 Jan; 108(1):207-13. PubMed ID: 18028989
[TBL] [Abstract][Full Text] [Related]
10. Borderline ovarian tumors in Denmark 1997-2018: Time trends in incidence by histology, age and educational level.
Baandrup L; Faber MT; Aalborg GL; Kjaer SK
Acta Obstet Gynecol Scand; 2021 Mar; 100(3):436-443. PubMed ID: 33010027
[TBL] [Abstract][Full Text] [Related]
11. Borderline ovarian tumors in Finland: epidemiology and familial occurrence.
Auranen A; Grénman S; Mäkinen J; Pukkala E; Sankila R; Salmi T
Am J Epidemiol; 1996 Sep; 144(6):548-53. PubMed ID: 8797514
[TBL] [Abstract][Full Text] [Related]
12. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer.
Gotlieb WH; Chetrit A; Menczer J; Hirsh-Yechezkel G; Lubin F; Friedman E; Modan B; Ben-Baruch G;
Gynecol Oncol; 2005 Jun; 97(3):780-3. PubMed ID: 15893369
[TBL] [Abstract][Full Text] [Related]
13. Trends in incidence of and mortality from uterine and ovarian cancer in Mid and South Limburg, The Netherlands, 1986-2003.
Kellert IM; Botterweck AA; Huveneers JA; Dirx MJ
Eur J Cancer Prev; 2009 Feb; 18(1):85-9. PubMed ID: 19077569
[TBL] [Abstract][Full Text] [Related]
14. [Ovarian cancer and borderline tumors].
Bjørge T; Engeland A; Hansen S; Tropé CG
Tidsskr Nor Laegeforen; 1998 Jun; 118(16):2471-5. PubMed ID: 9667122
[TBL] [Abstract][Full Text] [Related]
15. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
[TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer incidence (1989-1991) and mortality (1954-1993) in The Netherlands.
Koper NP; Kiemeney LA; Massuger LF; Thomas CM; Schijf CP; Verbeek AL
Obstet Gynecol; 1996 Sep; 88(3):387-93. PubMed ID: 8752245
[TBL] [Abstract][Full Text] [Related]
17. Familial invasive and borderline ovarian tumors by proband status, age and histology.
Hemminki K; Granström C
Int J Cancer; 2003 Jul; 105(5):701-5. PubMed ID: 12740921
[TBL] [Abstract][Full Text] [Related]
18. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.
Huusom LD; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
Cancer Causes Control; 2006 Aug; 17(6):821-9. PubMed ID: 16783610
[TBL] [Abstract][Full Text] [Related]
19. Second neoplasms after invasive and borderline ovarian cancer.
Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
[TBL] [Abstract][Full Text] [Related]
20. The incidence of ovarian cancer in Sweden, 1960-1984.
Adami HO; Bergström R; Persson I; Sparén P
Am J Epidemiol; 1990 Sep; 132(3):446-52. PubMed ID: 2389749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]